4,466 posts
annamacmillan

@annamacmillan

twitter.com/annamacmillan
Red Cross Intl. Smile! is the best medicine :-) Follow me & I'll follow you back

4,466 Posts by annamacmillan

5 Leadership Toys for the Multigenerational Workplace Sandbox - Forbes

forbes.com/sites/meghanbiro/2012/05/28/5-leadersh...oys-for-the-multigenerational-workplace-sandbox/

EMA confirms Roche's MabThera made at Vacaville site poses no health risk: ... which generated first-quarter 201...

thepharmaletter.com/file/113652/ema-confirms-roch...made-at-vacaville-site-poses-no-health-risk.html

EMA confirms Roche's MabThera made at Vacaville site poses no health risk: ... which generated first-quarter 201...

thepharmaletter.com/file/113652/ema-confirms-roch...made-at-vacaville-site-poses-no-health-risk.html

Spanish debt costs spiral as crisis deepens | Reuters

reuters.com/article/2012/05/28/us-spain-finances-idUSBRE84R0O820120528

Tranzyme and Norgine's ulimorelin fails to meet endpoints -

thepharmaletter.com/file/113628/tranzyme-and-norgines-ulimorelin-fails-to-meet-endpoints.html

Tranzyme and Norgine's ulimorelin fails to meet endpoints -

thepharmaletter.com/file/113628/tranzyme-and-norgines-ulimorelin-fails-to-meet-endpoints.html

EMA unit backs approval of Jentadueto; Agency updates on Pradaxa - Pharmaceutical and Biotechnology News - Pharma Letter

thepharmaletter.com/file/113654/ema-unit-backs-approval-of-jentadueto-agency-updates-on-pradaxa.html

Patent losses will drive generics in cardiovascular diseases market to 2018 - Pharmaceutical and Biotechnology News - Pharma Letter

thepharmaletter.com/file/113625/patent-losses-wil...s-in-cardiovascular-diseases-market-to-2018.html

Patent losses will drive generics in cardiovascular diseases market to 2018 - Pharmaceutical and Biotechnology News - Pharma Letter

thepharmaletter.com/file/113625/patent-losses-wil...s-in-cardiovascular-diseases-market-to-2018.html
Page 1 of 100
  • share this profile on Twitter
  • rss subscribe to this profile